GlassScriptPhysician profile
Marina Perazzo
NPI 1386650489
$4,502.39
in general payments reported to CMS, 2019-2025
22 companies · $1,064 in 2025
The $1,064 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $903 · 2022: $722 · 2023: $740 · 2024: $1,073 · 2025: $1,064.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,877.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,876.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $913.60 | 2021-2025 | Wavewriter Alpha Prime 16, Intracept Rf Probe |
| Mml US, INC. | $761.37 | 2024-2025 | Reactiv8 |
| Vertos Medical, INC. | $582.78 | 2021-2023 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $319.00 | 2023-2025 | Xtampza |
| Nalu Medical, INC. | $297.56 | 2021-2023 | Nalu Neurostimulation System |
| Spinal Simplicity, LLC | $263.11 | 2024-2025 | Ha Minuteman G3-R |
| Saluda Medical Americas, INC. | $260.52 | 2022 | |
| Scilex Pharmaceuticals INC. | $212.54 | 2023-2025 | Ztlido |
| Painteq LLC | $190.84 | 2021-2024 | Painteq |
| Abbott Laboratories | $123.21 | 2021-2022 | |
| Protega Pharmaceutials INC | $94.48 | 2023-2024 | Roxybond |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $84.79 | 2021-2025 | Relistor |
| Vertex Pharmaceuticals Incorporated | $83.77 | 2024-2025 | |
| Abbvie INC. | $61.05 | 2022-2024 | |
| Forte Bio-Pharma LLC | $58.69 | 2021-2025 | Prolate, Tanlor, Nalocet |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valinor Pharma, LLC | $56.94 | 2025 | Movantik |
| Merz Pharmaceuticals, LLC | $41.89 | 2024 | Xeomin |
| Averitas Pharma INC. | $23.22 | 2025 | Qutenza |
| Biohaven Pharmaceutical Holding Company LTD. | $19.71 | 2022 | |
| Ibsa Pharma INC. | $18.84 | 2025 | Tirosint, Flector, Licart |
| Pfizer INC. | $17.35 | 2024 | |
| Almatica Pharma LLC | $17.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marina Perazzo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.